Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed. C. pneumoniae were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations. C. trachomatis was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by C. pneumoniae in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.
This is a preview of subscription content, access via your institution.
References
- 1.
A. V. Morgun, N. V. Kuvacheva, Yu. K. Komleva, et al., Ann. Klin. Eksp. Nevrol., 6, No. 2, 42-51 (2012).
- 2.
E. Boelen, H. W. Steinbusch, A. J. van der Ven, et al., Neurobiol. Aging, 28, No. 4, 524-532 (2006).
- 3.
J. Boman, P. M. Roblin, P. Sundstrom, et al., Neurology, 54, No. 1, 265 (2000).
- 4.
C. Breithaupt, A. Schubart, H. Zander, et al., Proc. Natl Acad. Sci. USA, 100, No. 16, 9446-9451 (2003).
- 5.
T. Derfuss, R. Gurkov, F. Then Bergh, et al., Brain, 124, Pt 7, 1325-1335 (2001).
- 6.
C. Du, S. Y. Yao, A. Ljunggren-Rose, and S. Sriram, J. Exp. Med., 196, No. 12, 1639-1644 (2002).
- 7.
S. J. Furrows, J. C. Hartley, J. Bell, et al., J. Neurol. Neurosurg. Psychiatry, 75, No. 1, 152-154 (2004).
- 8.
Q. Hao, N. Miyashita, M. Matsui, et al., Mult. Scler., 8, No. 5, 436-440 (2002).
- 9.
L. J. Heung, C. Luberto, and M. Del Poeta, Infect. Immun., 74, No. 1, 28-39 (2006).
- 10.
D. Krametter, G. Niederwieser, A. Berghold, et al., Mult. Scler., 7, No. 1, 13-18 (2001).
- 11.
J. Paratt, R. Tavendale, J. O’Riordan, et al., Ibid., 14, No. 3, 292-299 (2008).
- 12.
C. H. Polman, S. C. Reingold, B. Banwell, et al., Ann. Neurol., 69, No. 2, 292-302 (2011).
- 13.
S. Sriram, W. Mitchell, and C. Stratton, Neurology, 50, No. 2, 571-572 (1998).
- 14.
T. Vainas, R. De Graaf, F. R. Stassen, et al., APMIS, 111, No. 2, 363-369 (2003).
- 15.
F. C. Westall, J. Clin. Microbiol., 44, No. 6, 2099-2104 (2006).
Author information
Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 159, No. 5, pp. 605-608, May, 2015
Rights and permissions
About this article
Cite this article
Ivanova, M.V., Kolkova, N.I., Morgunova, E.Y. et al. Role of Chlamydia in Multiple Sclerosis. Bull Exp Biol Med 159, 646–648 (2015). https://doi.org/10.1007/s10517-015-3037-z
Received:
Published:
Issue Date:
Key Words
- multiple sclerosis
- Chlamydia